Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma.

Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma. Br J Cancer. 2012 Sep 25; 107(7):1009-16.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.